Structure-based drug discovery of carbonic anhydrase inhibitors
Top Cited Papers
- 2 April 2012
- journal article
- review article
- Published by Taylor & Francis in Journal of Enzyme Inhibition and Medicinal Chemistry
- Vol. 27 (6) , 759-772
Abstract
Inhibition of the metalloenzyme carbonic anhydrase (CA; EC 4.2.1.1) has pharmacologic applications in the field of anti-glaucoma, anti-convulsant and anti-cancer agents. But recently, it has also emerged that these enzymes have the potential for designing anti-infective drugs (anti-fungal and anti-bacterial agents) with a novel mechanism of action. Sulphonamides and their isosteres (sulphamates/sulphamides) constitute the main class of CA inhibitors (CAIs), which bind to the metal ion from the enzyme active site. Recently, the dithiocarbamates (DTCs), possessing a similar mechanism of action, were reported as a new class of inhibitors. These types of CAIs will be discussed in detail in this review. Novel drug design strategies have been reported ultimately based on the tail approach for obtaining sulphonamides/DTCs, which exploit more external binding regions within the enzyme active site (in addition to coordination to the metal ion), leading thus to isoform-selective compounds. Most of the promising data have been obtained by combining x-ray crystallography of enzyme-inhibitor adducts with novel synthetic approaches for generating chemical diversity. Whereas sulphonamide – NO donating hybrid drugs were reported as effective anti-glaucoma agents, most of the interesting new inhibitors were designed for inhibiting specifically the tumour-associated isoforms CA IX and XII, validated targets for imaging and treatment of hypoxic tumours. Promising compounds that inhibit CAs from bacterial and fungal pathogens, of the DTC and carboxylate types, will be also reviewed.Keywords
This publication has 81 references indexed in Scilit:
- Interfering with pH regulation in tumours as a therapeutic strategyNature Reviews Drug Discovery, 2011
- Carbonic Anhydrase Inhibitors and Activators for Novel Therapeutic ApplicationsFuture Medicinal Chemistry, 2011
- Bacterial Carbonic Anhydrases as Drug Targets: Toward Novel Antibiotics?Frontiers in Pharmacology, 2011
- Carbonic anhydrase inhibitorsBioorganic & Medicinal Chemistry Letters, 2010
- Entrapment of Carbon Dioxide in the Active Site of Carbonic Anhydrase IIJournal of Biological Chemistry, 2008
- Structure and metal exchange in the cadmium carbonic anhydrase of marine diatomsNature, 2008
- Carbonic anhydrases: novel therapeutic applications for inhibitors and activatorsNature Reviews Drug Discovery, 2008
- Review ArticleJournal of Enzyme Inhibition and Medicinal Chemistry, 2004
- Carbonic anhydrase inhibitorsMedicinal Research Reviews, 2002
- Carbonic anhydrase is an ancient enzyme widespread in prokaryotesProceedings of the National Academy of Sciences, 1999